Biogen Idec CEO James Mullen: An Interview With “The Pink Sheet” DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is “open for business” on deals, Mullen says during break at Massachusetts Biotechnology Council investor conference.